Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Jul 09, 2024 6:54am
637 Views
Post# 36123958

Smart move by TLT management...

Smart move by TLT management...In the Newsrelease it is clearly stipulated that this is a Non-Brokered Private Placement.

With a Non-Brokered Private Placement, it is TLT(not a broker that doesn't care) that decide to who they are going to sells the shares. TLT has to hand-select each investors one by one, it is a time-consuming process, that could explain why it is done in tranches.

By doing a Non-Brokered Private Placement where TLT hand-select each investors(insider, friends...etc), the company(TLT) is making sure a big stack of shares will not be acquired by unfriendly hands.

It could be possible that at this point in time, having a big foot inside the FDA, and being so close to Pre-BTD and BTD approval, TLT decided that it was to the advantage of the company to do a Non-Brokered Private Placement.

Whatever the reason for now TLT has money to continue towards Pre-BTD and BTD approval.

I love my TLT shares.
<< Previous
Bullboard Posts
Next >>